GGrantIndex
← Leaderboards

Joachim H Ix

Tufts Medical Center

Google Scholar ↗PubMed ↗ORCID ↗
$16,690,262
Attributed
$32,891,894
Total exposure
15
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3M · FY2009–25
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$34,139,311 · 17

By mechanism

R01$22,171,280 · 9
U01$8,067,010 · 3
T32$1,265,202 · 1
P30$795,873 · 1
K24$780,384 · 1
R21$608,018 · 1

Top collaborators

Most similar at Tufts Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Chronic Kidney Failure”

Research focus

Chronic Kidney FailureUrineEventRisk FactorsHigh RiskKidney DiseasesPersonsKidneyCardiovascular DiseasesRenal FunctionBaseParticipantFollow-UpSerumFibrosisBiological MarkersCardiovascular Disorder RiskFunctional DisorderPublic Health RelevanceMortalityCohortDisease ProgressionInsightLead

Grant awards (70)

Environmental Metal Toxicity and Kidney Tubule Measures in Diverse Populations$680,372
R01 · FY2025 · DK
NonInvasive Virtual Biopsy for Determining Bone Turnover in Chronic Kidney Disease$642,951
R01 · FY2025 · AR
Dimensions of Kidney Tubule Health and Atherosclerotic Cardiovascular Disease and Heart Failure in Middle-Aged and Older Adults$625,475
R01 · FY2025 · HL
The San Diego Regional Network Award for Kidney, Urologic, and Hematologic Research Training$225,772
U2C · FY2025 · DK · contact PI
NonInvasive Virtual Biopsy for Determining Bone Turnover in Chronic Kidney Disease$765,546
R01 · FY2024 · AR
Environmental Metal Toxicity and Kidney Tubule Measures in Diverse Populations$738,587
R01 · FY2024 · DK
Dimensions of Kidney Tubule Health and Atherosclerotic Cardiovascular Disease and Heart Failure in Middle-Aged and Older Adults$680,241
R01 · FY2024 · HL
Kidney Tubule Dysfunction and Future Risk of Acute Kidney Injury$621,154
R01 · FY2024 · DK · contact PI
The San Diego Regional Network Award for Kidney, Urologic, and Hematologic Research Training$225,772
U2C · FY2024 · DK · contact PI
Dimensions of Kidney Tubule Health and Atherosclerotic Cardiovascular Disease and Heart Failure in Middle-Aged and Older Adults$773,777
R01 · FY2023 · HL
Kidney Tubule Dysfunction and Future Risk of Acute Kidney Injury$682,173
R01 · FY2023 · DK · contact PI
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease$591,938
R01 · FY2023 · DK · contact PI
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP-CKD)$523,979
U01 · FY2023 · DK · contact PI
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP-CKD)$349,999
U01 · FY2023 · DK · contact PI
Kidney Tubule Dysfunction and Future Risk of Acute Kidney Injury$694,270
R01 · FY2022 · DK · contact PI
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP-CKD)$577,221
U01 · FY2022 · DK · contact PI
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease$576,792
R01 · FY2022 · DK · contact PI
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP–CKD)$200,000
U01 · FY2022 · DK · contact PI
Kidney Tubule Dysfunction and Future Risk of Acute Kidney Injury$753,624
R01 · FY2021 · DK · contact PI
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease$650,208
R01 · FY2021 · DK · contact PI
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP–CKD)$599,552
U01 · FY2021 · DK · contact PI
Effects of Iron Deficiency, Inflammation, and Kidney Clearance on Circulating Fibroblast Growth Factor-23 Concentrations$320,836
R01 · FY2021 · DK · contact PI
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP–CKD)$150,000
U01 · FY2021 · DK · contact PI
Kidney Tubule Dysfunction and Future Risk of Acute Kidney Injury$1
R01 · FY2021 · DK · contact PI
Kidney Tubular Injury and Dysfunction and Racial Disparities in Incident Hypertension and Kidney Function Decline$795,873
P30 · FY2020 · DK
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease$664,281
R01 · FY2020 · DK · contact PI
Beyond the Glomerulus: Novel Clinical Markers of Kidney Health and Prognosis$472,837
U01 · FY2020 · DK
Effects of Iron Deficiency, Inflammation, and Kidney Clearance on Circulating Fibroblast Growth Factor-23 Concentrations$318,745
R01 · FY2020 · DK · contact PI
Mentored Patient Oriented Research in Kidney Disease$173,565
K24 · FY2020 · DK · contact PI
Adult and Pediatric Nephrology Clinical Investigation Training Program$159,398
T32 · FY2020 · DK · contact PI
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP–CKD)$652,305
U01 · FY2019 · DK · contact PI
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease$644,112
R01 · FY2019 · DK · contact PI
Effects of Iron Deficiency, Inflammation, and Kidney Clearance on Circulating Fibroblast Growth Factor-23 Concentrations$378,461
R01 · FY2019 · DK · contact PI
Adult and Pediatric Nephrology Clinical Investigation Training Program$277,956
T32 · FY2019 · DK · contact PI
Beyond the Glomerulus: Novel Clinical Markers of Kidney Health and Prognosis$249,984
U01 · FY2019 · DK
Mentored Patient Oriented Research in Kidney Disease$173,538
K24 · FY2019 · DK · contact PI
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP–CKD)$666,605
U01 · FY2018 · DK · contact PI
Adult and Pediatric Nephrology Clinical Investigation Training Program$250,796
T32 · FY2018 · DK · contact PI
Beyond the Glomerulus: Novel Clinical Markers of Kidney Health and Prognosis$250,000
U01 · FY2018 · DK
Mentored Patient Oriented Research in Kidney Disease$171,893
K24 · FY2018 · DK · contact PI
Adult and Pediatric Nephrology Clinical Investigation Training Program$76,233
T32 · FY2018 · DK · contact PI
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney$570,855
R01 · FY2017 · DK · contact PI
A Novel Approach to Phosphorus Lowering in Patients with Chronic Kidney Disease$427,935
U01 · FY2017 · DK · contact PI
Adult and Pediatric Nephrology Clinical Investigation Training Program$253,358
T32 · FY2017 · DK · contact PI
Mentored Patient Oriented Research in Kidney Disease$175,540
K24 · FY2017 · DK · contact PI
Beyond the Glomerulus: Novel Clinical Markers of Kidney Health and Prognosis$99,997
U01 · FY2017 · DK
Adult and Pediatric Nephrology Clinical Investigation Training Program$83,766
T32 · FY2017 · DK · contact PI
Beyond the Glomerulus: Novel Clinical Markers of Kidney Health and Prognosis$794,962
U01 · FY2016 · DK
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney$607,359
R01 · FY2016 · DK · contact PI
A Novel Approach to Phosphorus Lowering in Patients with Chronic Kidney Disease$524,445
U01 · FY2016 · DK · contact PI
Effects of Niacin on Mineral Metabolism in Chronic Kidney Disease$300,624
R01 · FY2016 · DK · contact PI
Adult and Pediatric Nephrology Clinical Investigation Training Program$163,695
T32 · FY2016 · DK · contact PI
Mentored Patient Oriented Research in Kidney Disease$85,848
K24 · FY2016 · DK · contact PI
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney$608,653
R01 · FY2015 · DK · contact PI
A Novel Approach to Phosphorus Lowering in Patients with Chronic Kidney Disease$511,543
U01 · FY2015 · DK · contact PI
Effects of Niacin on Mineral Metabolism in Chronic Kidney Disease$302,765
R01 · FY2015 · DK · contact PI
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney$653,166
R01 · FY2014 · DK · contact PI
Effects of Niacin on Mineral Metabolism in Chronic Kidney Disease$585,059
R01 · FY2014 · DK · contact PI
A Novel Approach to Phosphorus Lowering in Patients with Chronic Kidney Disease$519,335
U01 · FY2014 · DK · contact PI
A Novel Approach to Phosphorus Lowering in Patients with Chronic Kidney Disease$496,311
U01 · FY2013 · DK · contact PI
Determinants and Cardiovascular Consequences of Diabetes in Older Adults$1,294,893
R01 · FY2012 · HL
Determinants and Cardiovascular Consequences of Diabetes in Older Adults$1,397,528
R01 · FY2011 · HL
Fetuin-A and Incident Cardiovascular Disease, Fracture, and Diabetes$247,800
R01 · FY2011 · HL · contact PI
Determinants and Cardiovascular Consequences of Diabetes in Older Adults$1,440,971
R01 · FY2010 · HL
Fetuin-A and Incident Cardiovascular Disease, Fracture, and Diabetes$283,200
R01 · FY2010 · HL · contact PI
Fetuin-A: A Novel Biomarker of Vascular Calcification and Diabetes Mellitus$198,343
R21 · FY2010 · HL · contact PI
Determinants and Cardiovascular Consequences of Diabetes in Older Adults$1,720,863
R01 · FY2009 · HL
Fetuin-A and Incident Cardiovascular Disease, Fracture, and Diabetes$354,000
R01 · FY2009 · HL · contact PI
Fetuin-A: A Novel Biomarker of Vascular Calcification and Diabetes Mellitus$250,407
R21 · FY2009 · HL · contact PI
Fetuin-A: A Novel Biomarker of Vascular Calcification and Diabetes Mellitus$159,268
R21 · FY2009 · HL · contact PI